Regulation of DNA double-strand break repair pathways in multiple myeloma
Regulation of DNA double-strand break repair pathways in multiple myeloma
批准号:
356118
负责人:
Orthwein Alexandre
金额:
$62.14万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-10-01 至 2021-10-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Multiple Myeloma (MM) is the second most common hematological malignancy in Canada. Due to its heterogeneity, a large portion of patients affected by MM is refractory to or relapses from first line therapies, including the proteasome inhibitor (PI) Bortez
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Reseach Chair - Tier 2
-
批准号:454225
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2021
-
负责人:Orthwein Alexandre
-
依托单位:
CRC Tier 2
-
批准号:364809
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2016
-
负责人:Orthwein Alexandre
-
依托单位:
From genetic diversity to genomic instability: in vivo characterization of the deubiquitinase OTUB1 in B-cells
-
批准号:341581
-
项目类别:Operating Grants
-
资助金额:$61.26万
-
财政年份:2016
-
负责人:Orthwein Alexandre
-
依托单位:
Importance of cyclin D1-USP11 interaction for the homologous repair pathway
-
批准号:253826
-
项目类别:Fellowship Programs
-
资助金额:$9.83万
-
财政年份:2012
-
负责人:Orthwein Alexandre
-
依托单位:
海外基金